Immunization with Components of Two Iron Uptake ABC Transporters Protects Mice against Systemic Streptococcus pneumoniae Infection
Open Access
- 1 November 2001
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (11) , 6702-6706
- https://doi.org/10.1128/iai.69.11.6702-6706.2001
Abstract
There has been considerable recent research into protein based Streptococcus pneumoniae vaccines as alternatives to the existing capsular antigen vaccines. PiuA and PiaA (formerly Pit1A and Pit2A) are recently identified lipoprotein components of S. pneumoniae iron uptake ABC transporters which are required for full virulence and are likely to be expressed on the surface of the bacterial cell membrane. We investigated the efficacy of recombinant PiuA and PiaA proteins at eliciting protective immunity in mice against systemic infection with S. pneumoniae . Both recombinant PiuA and PiaA generated antibody responses that cross-reacted with each other but not with pneumolysin and reacted with identical proteins from nine different S. pneumoniae serotypes. Mice immunized with recombinant PiuA and PiaA were protected against systemic challenge to a degree similar to those immunized with an existing protein vaccine candidate, PdB (a genetically modified pneumolysin toxoid). Immunization with a combination of both PiuA and PiaA resulted in additive protection and was highly protective against systemic infection with S. pneumoniae . PiuA and PiaA are therefore promising additional candidates for a novel S. pneumoniae vaccine using protein antigens.Keywords
This publication has 23 references indexed in Scilit:
- Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesThorax, 2001
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Immunization of Mice with Combinations of Pneumococcal Virulence Proteins Elicits Enhanced Protection against Challenge with Streptococcus pneumoniaeInfection and Immunity, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Systemic and Mucosal Protective Immunity to Pneumococcal Surface Protein AAnnals of the New York Academy of Sciences, 1996
- The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniaeTrends in Microbiology, 1996
- Truncated Streptococcus pneumoniae PspA Molecules Elicit Cross-Protective Immunity against Pneumococcal Challenge in MiceThe Journal of Infectious Diseases, 1996
- Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.Journal of Clinical Investigation, 1995
- Antibody Response to Pneumococcal Vaccination in Children Younger than Five Years of AgeThe Journal of Infectious Diseases, 1983
- STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPESThe Journal of Experimental Medicine, 1944